These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5607868)

  • 1. [Significance of anticoagulants in the treatment of cardiac insufficiency in patients with rheumatic defects of the heart].
    KushelevskiÄ­ BP; Rozhdestvenskaia ED
    Sov Med; 1967 Jul; 30(7):28-32. PubMed ID: 5607868
    [No Abstract]   [Full Text] [Related]  

  • 2. [Time organization of blood coagulation in patients with rheumatic heart disease involving circulation insufficiency].
    Zaslavskaia RM; Logvinenko SI; Teiblium MM; Khalberg F
    Klin Med (Mosk); 1996; 74(8):25-9. PubMed ID: 9036201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of rheumatic heart disease with long-term use of anticoagulants.
    POMERANTZ HZ; SHISTER HE
    Can Med Assoc J; 1954 Sep; 71(3):272-3. PubMed ID: 13190488
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulant treatment and cardiac insufficiency].
    Bounhoure JP; Galinier M; Pathak A
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():29-32. PubMed ID: 10830086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we use anticoagulation for patients with chronic heart failure?
    Freudenberger RS; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2006 Nov; 3(11):580-1. PubMed ID: 17063158
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interrelation between adenine/nucleotides and fatty acids in patients with rheumatic heart disease with cardiac insufficiency].
    Neverov IV; Novikov VT; Spinova RP; Kozlova RI
    Klin Med (Mosk); 1987 Jul; 65(7):66-70. PubMed ID: 3669575
    [No Abstract]   [Full Text] [Related]  

  • 7. [Characteristics of dyslipidemia in cardiac insufficiency in patients with rheumatic heart defects].
    Neverov IV; Spinova RP; Novikov VT
    Klin Med (Mosk); 1987 Jun; 65(6):123-6. PubMed ID: 3626446
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heart failure and arrhythmia: modalities and indications of prevention of thromboembolism].
    Prati PL; Piazza V
    Cardiologia; 1994 Dec; 39(12 Suppl 1):353-6. PubMed ID: 7634296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic heart failure in patients with mitral and aortic valve defects of rheumatic origin].
    Bagirova GG; Batalina MV
    Ter Arkh; 2000; 72(9):63-6. PubMed ID: 11076422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation in patients with atrial fibrillation and congestive heart failure.
    Veloso HH; de Paola AA
    Am J Cardiol; 2005 Jun; 95(12):1533. PubMed ID: 15950594
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiotonic activity of L-DOPA in the treatment of patients with chronic circulatory insufficiency].
    Khrustalev OA
    Ter Arkh; 1980; 52(9):104-8. PubMed ID: 7434220
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulation in chronic heart failure and left ventricular dysfunction].
    Wichter T; Breithardt G
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2145-8. PubMed ID: 12397561
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of ethacrynic acid in the surgical clinical aspects of patients with rheumatic heart diseases and circulatory insufficiency].
    MalinovskiÄ­ NN; Golubev IS; Tarichko IuV
    Sov Med; 1971 Apr; 34(4):118-22. PubMed ID: 5143737
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic and prophylactic use of anticoagulants in rheumatic heart disease].
    ROZENBLAT FIa; SHMIDT ED
    Klin Med (Mosk); 1959 May; 37(5):71-6. PubMed ID: 13665925
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of cardiac glycosides in circulatory insufficiency].
    Vizir AD
    Vrach Delo; 1969 Nov; 11():39-42. PubMed ID: 5384419
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombotic therapy in heart failure.
    Verheugt FW
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):277-8. PubMed ID: 16716103
    [No Abstract]   [Full Text] [Related]  

  • 17. [For which patients with cardiac decompensation is prevention of thromboembolism advisable?].
    G Ital Cardiol; 1994 Oct; 24(10):1341-6. PubMed ID: 7835568
    [No Abstract]   [Full Text] [Related]  

  • 18. Left ventricular thrombus and the incidence of thromboembolism in patients with congestive heart failure: can clinical factors identify patients at increased risk?
    Katz SD
    J Cardiovasc Risk; 1995 Apr; 2(2):97-102. PubMed ID: 7606657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of anticoagulants in patients with congestive heart failure].
    da Silva MA
    Arq Bras Cardiol; 1994 Mar; 62(3):205. PubMed ID: 7980085
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk].
    Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.